Search
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Abnova
CYLC2 Polyclonal Antibody, MaxPab™
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
产品信息
H00001539-B01P
产品规格
种属反应
Human
宿主/亚型
Mouse
/ IgG
分类
Polyclonal
类型
Antibody
抗原
CYLC2 (NP_001331.1, 1 a.a. approximately 348 a.a) full-length human protein.
偶联物
形式
Liquid
浓度
0.5 mg/mL
纯化类型
Protein A
保存液
PBS, pH 7.4
内含物
no preservative
保存条件
-20°C, Avoid Freeze/Thaw Cycles
运输条件
Ambient (domestic); Wet ice (international)
产品详细信息
Product may be used with Western Blot (Transfected lysate).
The Isotype of this product is composed of an IgG Mixture.
Immunogen sequence: MSLPRFQRVN FGPYDNYIPV SELSKKSWNQ QHFALLFPKP QRPGTKRRSK PSQIRDNTVS IIDEEQLRGD RRQPLWMYRS LMRISERPSV YLAARRQPLK PTRTVEVDSK AAEIGKKGED KTTQKDTTDS ESELKQGKKD SKKGKDIEKG KEEKLDAKKD SKKGKKDAEK GKDSATESED EKGGAKKDNK KDKKDSNKGK DSATESEGEK GGTEKDSKKG KKDSKKGKDS AIELQAVKAD EKKDEDGKKD ANKGDESKDA KKDAKEIKKG KKDKKKPSST DSDSKDDVKK ESKKDATKDA KKVAKKDTEK ESADSKKDAK KNAKKDAKKD AKKNAKKDEK KDAKKKGK
靶标信息
Possible architectural role during spermatogenesis. May be involved in spermatid differentiation.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
生物信息学
蛋白别名: Cylicin II; cylicin, basic protein of sperm head cytoskeleton 2; Cylicin-2; Multiple-band polypeptide II
基因别名: CYL2; CYLC2
UniProt ID: (Human) Q14093
Entrez Gene ID: (Human) 1539
